Stockrabit · Analysts
Questions across 1 call

Kunal Lakhani

CLSA

Dr. Lal Path Labs Ltd.

Dr. Lal Path Labs Ltd. CC-Mar25.pdf · 2025-04-25
Hi, good evening. Just a follow -up on an earlier remark. You said that the radiology revenue mix is less than 5%. Is that a conscious strategy to keep the concentration lower or it could be a revenue driver for future? What's the thought process there?
Sure. I mean, the reason why I was asking that was because we do have plans to expand in the South and some of our Southern peers have a very strong radiology mix, which kind of in a way helps them in terms of branding and sort of brand recall. You think that would not be an issue for us when it comes to expanding South India?